These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32849514)

  • 1. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H
    Front Immunol; 2020; 11():1505. PubMed ID: 32849514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Hao B; Gao S; Sang YW; Wang L; Meng XQ; You JY
    J Zhejiang Univ Sci B; 2019 Oct.; 20(10):849-860. PubMed ID: 31489804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.
    Jacobson CA; Sun L; Kim HT; McDonough SM; Reynolds CG; Schowalter M; Koreth J; Cutler CS; Ho VT; Alyea EP; Armand P; Blazar BR; Soiffer RJ; Antin JH; Ritz J; Sarantopoulos S
    Biol Blood Marrow Transplant; 2014 May; 20(5):668-75. PubMed ID: 24462743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Washel WS; Bhuiya NS; Cutler CS; Alyea EP; Ho VT; Soiffer RJ; Antin JH; Ritz J
    Blood; 2011 Feb; 117(7):2275-83. PubMed ID: 21097674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation.
    Wechalekar A; Cranfield T; Sinclair D; Ganzckowski M
    Clin Lab Haematol; 2005 Aug; 27(4):247-9. PubMed ID: 16048492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Cutler CS; Bhuiya NS; Schowalter M; Ho VT; Alyea EP; Koreth J; Blazar BR; Soiffer RJ; Antin JH; Ritz J
    Blood; 2009 Apr; 113(16):3865-74. PubMed ID: 19168788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
    Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q
    J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of autoantibody expression in allogeneic stem-cell recipients.
    Moon JH; Lee SJ; Kim JG; Chae YS; Kim SN; Kang BW; Suh JS; Lee KS; Sohn SK
    Transplantation; 2009 Jul; 88(2):242-50. PubMed ID: 19623021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia.
    Kuzmina Z; Greinix HT; Weigl R; Körmöczi U; Rottal A; Frantal S; Eder S; Pickl WF
    Blood; 2011 Feb; 117(7):2265-74. PubMed ID: 21063025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells in chronic graft-versus-host disease.
    McManigle W; Youssef A; Sarantopoulos S
    Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of Autoantibody Expression During Long-Term Follow-Up in Paediatric ALL Patients After Allogeneic Haematopoietic Stem Cell Transplantation.
    Lawitschka A; Ronceray L; Bauer D; Rittenschober M; Zubarovskaya N; Geyeregger R; Pickl WF; Kuzmina Z
    Front Pediatr; 2021; 9():788360. PubMed ID: 34993166
    [No Abstract]   [Full Text] [Related]  

  • 12. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.
    Allen JL; Fore MS; Wooten J; Roehrs PA; Bhuiya NS; Hoffert T; Sharf A; Deal AM; Armistead P; Coghill J; Gabriel DA; Irons R; Essenmacher A; Shea TC; Richards K; Cutler C; Ritz J; Serody J; Baldwin AS; Sarantopoulos S
    Blood; 2012 Sep; 120(12):2529-36. PubMed ID: 22896003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
    Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ
    Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.
    Kryštůfková O; Barbasso Helmers S; Venalis P; Malmström V; Lindroos E; Vencovský J; Lundberg IE
    Arthritis Res Ther; 2014 Oct; 16(5):454. PubMed ID: 25301447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation.
    Jia W; Poe JC; Su H; Anand S; Matsushima GK; Rathmell JC; Maillard I; Radojcic V; Imai K; Reyes NJ; Cardona DM; Li Z; Suthers AN; Curry-Chisolm IM; DiCioccio RA; Saban DR; Chen BJ; Chao NJ; Sarantopoulos S
    Blood; 2021 May; 137(18):2544-2557. PubMed ID: 33534893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation.
    Diep PP; Rueegg CS; Burman MM; Brinch L; Bø K; Fosså K; Landrø L; Loge JH; Lund MB; Massey RJ; Myrdal OH; Pathak M; Rimstad L; Tanem KE; Tjønnfjord GE; Aaløkken TM; Ruud E
    J Adolesc Young Adult Oncol; 2023 Feb; 12(1):66-75. PubMed ID: 35544321
    [No Abstract]   [Full Text] [Related]  

  • 17. The predictive value of serum free light chain level early after allogeneic hematopoietic stem cell transplantation for chronic graft-versus-host disease, a preliminary study.
    Wang B; Liang Z; Liu W; Sun Y; Cen X; Dong Y; Ren H
    Clin Transplant; 2020 Jul; 34(7):e13865. PubMed ID: 32242991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Angiotensin type 1 receptor antibodies in chronic graft-versus-host disease.
    Chiron A; Bouaziz JD; Carmagnat M; Peffault de Latour R; Lafaurie-Bergeron A; Robin M; Xhaard A; Toubert A; Charron D; Guigue N; Socié G; Bengoufa D
    Transplantation; 2014 Aug; 98(4):470-4. PubMed ID: 24873781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of the ratio of regulatory and effector T cells with recurrence and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Wang HT; Zhao XY; Zhao XS; Han TT; Lv M; Chang YJ; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):679-84. PubMed ID: 23978019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.